Velocity Clinical Research is currently enrolling patients for various clinical trials aimed at addressing significant health challenges, including high blood pressure, high cholesterol, diabetes, and weight management. These trials offer an opportunity for individuals with health improvement goals to participate in cutting-edge research and potentially benefit from novel therapeutic interventions.
The clinical trials involve a thorough initial health history screening, followed by continuous monitoring throughout the study duration. Velocity Clinical Research is focusing on studies related to cardiovascular health, metabolic disorders, and obesity.
GLP-1 Medications in Focus
Several trials are centered on newer GLP-1 (glucagon-like peptide-1) receptor agonists, available in both injectable and oral formulations. These medications have shown promise in managing weight and improving glycemic control. According to Dr. Matt Wenker, regional medical director for Velocity Clinical Research, GLP-1 medications work by "decreasing hunger, working in the satiety center to decrease your craving for food, delaying gastric emptying so the food stays in your stomach longer and they also help with insulin secretion."
Participation Details
Qualified participants will incur no costs for participating in the clinical trials and will be compensated for their time and travel expenses. This approach aims to reduce barriers to participation and ensure diverse representation in the studies.
Contact Information
Individuals interested in learning more about these clinical trials and determining their eligibility can contact Velocity Clinical Research at 984-666-5676 or visit their website.
